BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 10886590)

  • 1. Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients.
    Memoli B; Postiglione L; Cianciaruso B; Bisesti V; Cimmaruta C; Marzano L; Minutolo R; Cuomo V; Guida B; Andreucci M; Rossi G
    Kidney Int; 2000 Jul; 58(1):417-24. PubMed ID: 10886590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis-related lymphomononuclear release of interleukin-12 in patients with end-stage renal disease.
    Memoli B; Marzano L; Bisesti V; Andreucci M; Guida B
    J Am Soc Nephrol; 1999 Oct; 10(10):2171-6. PubMed ID: 10505694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD.
    Memoli B; Grandaliano G; Soccio M; Postiglione L; Guida B; Bisesti V; Esposito P; Procino A; Marrone D; Michael A; Andreucci M; Schena FP; Pertosa G
    J Am Soc Nephrol; 2005 Apr; 16(4):1099-107. PubMed ID: 15716332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C
    Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes.
    Memoli B; Minutolo R; Bisesti V; Postiglione L; Conti A; Marzano L; Capuano A; Andreucci M; Balletta MM; Guida B; Tetta C;
    Am J Kidney Dis; 2002 Feb; 39(2):266-73. PubMed ID: 11840366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of interleukin-6 and of its soluble receptors in the biocompatibility of dialysis treatment.
    Memoli B; Romano G; D'arcangelo R; Del Prete M; Esposito P; Procino A; Cuomo V; Bisesti V; Capuano A; Andreucci VE
    Semin Nephrol; 2004 Sep; 24(5):492-4. PubMed ID: 15490418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble IL-6 receptor levels in patients on chronic hemodialysis.
    Disthabanchong S; González EA; Martin KJ
    Clin Nephrol; 2002 Oct; 58(4):289-95. PubMed ID: 12400844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes.
    Pertosa G; Grandaliano G; Gesualdo L; Ranieri E; Monno R; Schena FP
    Kidney Int; 1998 Aug; 54(2):570-9. PubMed ID: 9690225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
    Linnenweber S; Lonnemann G
    Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells.
    Memoli B; Libetta C; De Nicola L; Rampino T; Capuano A; Guida B; Andreucci VE
    ASAIO J; 1996; 42(1):60-3. PubMed ID: 8808460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hemodialysis membranes on gene expression and plasma levels of interleukin-1 beta.
    Qian J; Yu Z; Dai H; Zhang Q; Chen S
    Artif Organs; 1995 Aug; 19(8):842-6. PubMed ID: 8573006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia.
    Goette NP; Lev PR; Heller PG; Glembotsky AC; Chazarreta CD; Salim JP; Molinas FC; Marta RF
    Exp Hematol; 2010 Oct; 38(10):868-876.e1. PubMed ID: 20600579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
    Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury: effect of hemodialysis membrane on Hgf and recovery of renal function.
    Libetta C; Esposito P; Sepe V; Rampino T; Zucchi M; Canevari M; Dal Canton A
    Clin Biochem; 2013 Jan; 46(1-2):103-8. PubMed ID: 23099196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
    Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients.
    Sasayama D; Wakabayashi C; Hori H; Teraishi T; Hattori K; Ota M; Ishikawa M; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2011 Nov; 45(11):1439-44. PubMed ID: 21700295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.